Market Cap
$2.22B$8.75B-79.74%
Summary
- Current Value
- As of today, RNA market cap is $2B, down -79.74% in the most recent trading session on
- Category
- Based on its current market cap, RNA falls into the Mid Cap category
- Historical Performance
- RNA market cap is down -79.55% year-to-date, down -36.42% year-over-year
- All-Time High Comparison
- RNA market cap is currently -79.78% below its historical high of $11B set on
- 3-Year Low Comparison
- RNA market cap is +515.86% above its 3-year low of $361M reached on
- Sector Comparison
- RNA market cap is higher than 80.46% of companies in Healthcare sector
Market Cap Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2B | -79.7% | -79.7% | -79.4% | -79.5% | -36.4% | +36.1% | +145.1% | |
| Price | $14.75 | -79.7% | -79.7% | -79.4% | -79.5% | -49.3% | -36.0% | -38.9% | |
| Shares Outstanding | 150.68M | 0.0% | – | – | – | +25.3% | +112.8% | +300.9% | |
| PE Ratio | - | – | – | – | – | – | – | – | |
| TTM Revenue | $18.76M | -10.1% | – | -10.1% | – | +72.1% | +103.3% | +176.3% | |
| TTM EPS | -$4.96 | -19.0% | – | -19.0% | – | -71.2% | -49.2% | -319.3% | |
| $574.85M | -93.8% | -93.8% | -93.6% | -93.8% | -71.3% | -44.3% | -0.8% | ||
| TTM Dividend Per Share | - | – | – | – | – | – | – | – | |
| TTM Net Income | -$684.63M | -24.5% | – | -24.5% | – | -112.4% | -293.5% | -1443.5% |
Market Cap Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | $11B | -79.8% | |
| 3M | $11B | -79.8% | |
| 6M | $11B | -79.8% | |
| 1Y | $11B | -79.8% | |
| 3Y | $11B | -79.8% | |
| 5Y | $11B | -79.8% | |
| All | $11B | -79.8% |
Market Cap Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | $2B | at low | |
| 3M | $2B | at low | |
| 6M | $2B | at low | |
| 1Y | $2B | at low | |
| 3Y | $361M | +515.9% | |
| 5Y | $361M | +515.9% | |
| All | $361M | +515.9% |
Market Cap History
| Date | Value | Change |
|---|---|---|
| $2B | -79.6% | |
| $11B | +211.7% | |
| $3B | +386.0% | |
| $717M | -53.7% |
| Date | Value | Change |
|---|---|---|
| $2B | +36.4% | |
| $1B | +18.4% | |
| $959M | - |
FAQ
What is the current market cap of RNA?
As of today, RNA market cap is $2B
What market cap category does RNA fall into?
Based on its current market cap, RNA falls into the Mid Cap category
What is RNA market cap today change?
RNA market cap is down -79.74% today
What is 1-year change in RNA market cap?
RNA market cap is down -36.42% year-over-year
How far is RNA market cap from its all-time high?
RNA market cap is currently -79.78% below its historical high of $11B set on February 3, 2026
How does RNA market cap rank versus sector peers?
RNA market cap is higher than 80.46% of companies in Healthcare sector
Market Cap Formula
Market Cap = Price × Shares Outstanding
Data Sources & References
- RNA Official Website www.aviditybiosciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1599901/000159990126000031/0001599901-26-000031-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990126000031/0001599901-26-000031-index.htm
- RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
- RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna